Technology Platform

  • MegaR Technology Platform

    It is well established that G protein-coupled receptors (GPCRs) exhibit significant instability during the purification process. Learn More >>

  • MegAb Membrane Protein Antibody Discovery Platform

    Currently, there are three major pain points in the discovery process of membrane protein antibodies (especially GPCRs) Learn More >>

  • Structural Biology Platform

    The MegaR systematizes the challenges of ligand-free GPCR/GPCR-antagonist structure elucidation. Learn More >>

  • AIDD&SBDD Platform (Partner with DP Technology)

    AIDD&SBDD Platform (Partner with DP Technology) Learn More >>

  • Small Molecule Drug Discovery Platform (Partner with HitGen)

    Small Molecule Drug Discovery Platform (Partner with HitGen) Learn More >>

Company Profile

Alphelix Biosciences is a biotechnology company focused on the early discovery of membrane protein drugs. Through several world leading membrane protein technology platforms with proprietary intellectual property, we provide global innovative pharmaceutical companies with one-stop services ranging from membrane protein target preparation and structural determination to the early discovery of antibodies, small molecules, and peptide drugs.

Learn More >>

For more information about our technology and services, please contact us.

Contact Us